Literature DB >> 19695468

Failure of guideline adherence for intervention in patients with severe mitral regurgitation.

David S Bach1, Mazen Awais, Hitinder S Gurm, Sarah Kohnstamm.   

Abstract

OBJECTIVES: This study sought to evaluate the incidence with which adult patients with significant mitral regurgitation (MR) do not undergo surgical intervention despite guideline recommendations, and the associated considerations resulting in no intervention.
BACKGROUND: Despite the existence of accepted guidelines, many patients with severe symptomatic heart valve disease might not undergo intervention.
METHODS: At a single large tertiary medical center, patients were retrospectively identified who had moderate-to-severe or severe MR on echocardiographic imaging during 2005. Clinical data were reviewed to determine indications for intervention and whether surgery was performed.
RESULTS: During 2005, 300 patients were identified with significant MR, including 188 with functional MR and 112 with organic MR. Mitral surgery was performed in 30 of 188 patients with functional MR, mostly to treat heart failure or during another cardiac surgical procedure. Mitral surgery was performed in 59 (53%) of 112 patients with organic MR. Among unoperated patients with organic MR, common reasons included stable left ventricular size or function, absence of symptoms, and prohibitive comorbidities. Using American College of Cardiology/American Heart Association guidelines, 1 or more indication for intervention was present in 39 (74%) of 53 unoperated patients. Perioperative mortality risk was not higher for patients who did not undergo surgery (median 1.2%, interquartile range [IQR] 0.4% to 3.3%) than for those who did (median 1.1%, IQR 0.6% to 5.3%; p = 0.71). During follow-up, there were 12 cardiac and 2 unexplained deaths.
CONCLUSIONS: Among patients with severe organic MR, surgical intervention occurred in approximately one-half. However, accepted guideline indications for intervention were present in the majority of unoperated patients. Objectively assessed operative risk was not prohibitive in many unoperated patients. 2009 by the American College of Cardiology Foundation

Entities:  

Mesh:

Year:  2009        PMID: 19695468     DOI: 10.1016/j.jacc.2009.03.079

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  25 in total

Review 1.  Minimally invasive heart valve surgery: how and why in 2012.

Authors:  Rakesh M Suri; Nassir M Thalji
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Can we predict mitral valve repair rates by individual surgeons' mitral volume?

Authors:  Steven F Bolling
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  Exercise echocardiography for structural heart disease.

Authors:  Masaki Izumo; Yoshihiro J Akashi
Journal:  J Echocardiogr       Date:  2016-01-13

Review 4.  Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies.

Authors:  Alec Vahanian; Bernard Iung; Dominique Himbert; Patrick Nataf
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-24       Impact factor: 2.357

5.  Degenerative Mitral Valve Repair Restores Life Expectancy.

Authors:  Tessa M F Watt; Alexander A Brescia; Shannon L Murray; David A Burn; Alexander Wisniewski; Matthew A Romano; Steven F Bolling
Journal:  Ann Thorac Surg       Date:  2019-08-28       Impact factor: 4.330

Review 6.  Treatment and management of mitral regurgitation.

Authors:  Michele De Bonis; Francesco Maisano; Giovanni La Canna; Ottavio Alfieri
Journal:  Nat Rev Cardiol       Date:  2011-11-22       Impact factor: 32.419

7.  Outcome and undertreatment of mitral regurgitation: a community cohort study.

Authors:  Volha Dziadzko; Marie-Annick Clavel; Mikhail Dziadzko; Jose R Medina-Inojosa; Hector Michelena; Joseph Maalouf; Vuyisile Nkomo; Prabin Thapa; Maurice Enriquez-Sarano
Journal:  Lancet       Date:  2018-03-10       Impact factor: 79.321

Review 8.  Degenerative mitral valve regurgitation: best practice revolution.

Authors:  David H Adams; Raphael Rosenhek; Volkmar Falk
Journal:  Eur Heart J       Date:  2010-07-11       Impact factor: 29.983

9.  How do we use imaging to aid considerations for intervention in patients with severe mitral regurgitation?

Authors:  Randolph P Martin
Journal:  Ann Cardiothorac Surg       Date:  2013-11

10.  Multicenter evaluation of high-risk mitral valve operations: implications for novel transcatheter valve therapies.

Authors:  Damien J LaPar; James M Isbell; Ivan K Crosby; John Kern; D Scott Lim; Edwin Fonner; Alan M Speir; Jeffrey B Rich; Irving L Kron; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2014-10-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.